Your browser doesn't support javascript.
loading
Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.
Ohtani, Ryo; Nakamura, Michikazu; Nirengi, Shinsuke; Kawakami, Osamu; Togawa, Jumpei; Doi, Kento; Sainouchi, Makoto; Kuwata, Yasuhiro; Takata, Masaki; Masuda, Yuichi; Matsunari, Ryota; Takeda, Kiyoaki; Tsukahara, Tetsuya; Sakane, Naoki.
Afiliação
  • Ohtani R; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan. Electronic address: ryoohtani@gmail.com.
  • Nakamura M; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Nirengi S; Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Kawakami O; Department of Neurosurgery, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Togawa J; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Doi K; Department of Neurosurgery, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Sainouchi M; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Kuwata Y; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Takata M; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Masuda Y; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Matsunari R; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Takeda K; Department of Neurology, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Tsukahara T; Department of Neurosurgery, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
  • Sakane N; Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Fukakusa, Kyoto, Japan.
J Stroke Cerebrovasc Dis ; 28(7): 1979-1986, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30982718
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pressão Sanguínea / Terapia Trombolítica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Hemorragias Intracranianas / Fibrinolíticos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pressão Sanguínea / Terapia Trombolítica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Hemorragias Intracranianas / Fibrinolíticos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article